CD8A and glioblastoma: Significant upregulation of VLA-4 expression was observed on CD8+ TEFF and CD8+ TSCM subsets from both groups (Figure 6, I and J, **P < 0.01 for healthy controls and ***P < 0.001 for glioblastoma patients).